Skip to content

SG&A at other companies

Humana logo
HumanaHUM
$4.02B+19.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
$15.39B+13.2%
Elevance Health logo
Elevance HealthELV
$6.33B+19.4%
Oscar Health logo
Oscar HealthOSCR
$706.23M+46.3%
Cencora logo
CencoraCOR
$1.98B+23.6%
Alignment Healthcare logo
Alignment HealthcareALHC
$121.14M+16.7%

Other financials

Income statement

See full
Revenue$49.9B+7.1%
Gross profit$49.2B+7.2%
Operating income$1.9B+21.3%
Net income$1.5B+17.5%
EPS (diluted)$3.11+18.3%

Balance sheet

See full
Cash & equivalents$21.3B+43.5%
Total debt$16.4B-10.6%
Total equity$21.4B-23.2%
Total assets$81.2B-6.7%

Cash flow

See full
Operating cash flow$4.4B+189%
CapEx$200.0M+48.1%
Free cash flow$4.2B+203%

Valuation

See full
Market cap$31.7B+19.0%
Enterprise value$26.8B-9.7%
P/S0.2×0.0×

Profitability

See full
Gross margin98.7%+0.3pp
Operating margin-3.7%-5.8pp
Net margin-3.3%-5.3pp
FCF margin3.6%+2.7pp

Returns & leverage

See full
Return on equity-26.1%-38.7pp
Debt / equity0.8×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Centene in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: Centene’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Centene's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Centene's SG&A?
Centene (CNC) reported SG&A of $3.4B in Q1 2026.
How has Centene's SG&A changed year-over-year?
Centene's SG&A increased by 1.3% year-over-year, from $3.35B to $3.4B.
What is the long-term trend for Centene's SG&A?
Over 4 years (2021 to 2025), Centene's SG&A has grown at a 7.7% compound annual growth rate (CAGR), from $9.6B to $12.9B.
What does SG&A mean?
Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.